Patents expiring in 2030

US 7811602

Liposomal formulations comprising dihydrosphingomyelin and methods of use thereof

Tekmira Pharmaceuticals Corporation · Granted Tue Oct 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7811563

Anti-addl antibodies and uses thereof

Northwestern University · Granted Tue Oct 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7811592

Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of Chlamydia

The Board of Regents of the University of Texas System · Granted Tue Oct 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7811603

Microfluidic device for forming monodisperse lipoplexes

The Regents of the University of California · Granted Tue Oct 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7811297

Actuable structures and methods of fabrication and use

TELEDYNE SCIENTIFIC & IMAGING, LLC · Granted Tue Oct 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7811550

Method for making magnetic fluorescent core shell nanoparticles

United States of America as represented by the Secretary of the Air Force · Granted Tue Oct 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7816538

Dimeric small molecule potentiators of apoptosis

The Board of Regents of the University of Texas System · Granted Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7816532

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7816086

Genes of an otitis media isolate of nontypeable Haemophilus influenzae

The Board of Regents of the University of Oklahoma · Granted Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7815921

Cytocapacity test for the prediction of the hematopoietic recovery, neutropenic fever, and antimicrobial treatment following high-dose cytotoxic chemotherapy

Ludwig-Maximilians-Universitat Munchen · Granted Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7815914

Methods for the treatment of cellular proliferative disorders

ONCOLYTICS BIOTECH INC. · Granted Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7815942

Rasagiline formulations of improved content uniformity

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7815908

Methods and compositions for treating and preventing disease associated with αVβ5 integrin

The Regents of the University of California · Granted Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7815916

Cloning and expression of HTLV-III DNA

The United States of America, as represented by the Secretary, Health and Human Services · Granted Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7816372

6-cycloamino-2-quinolinone derivatives as androgen receptor modulator compounds

Ligand Pharmaceuticals Incorporated · Granted Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7815935

Orally distintegrating formulation and process for preparing the same

Quantum Hi-Tech (Beijing) Research Institute · Granted Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7816075

Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents

Xenon Pharmaceuticals Inc. · Granted Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7816076

Therapeutic targets in cancer

Sagres Discovery, Inc. · Granted Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7816087

Gene expressed in prostate cancer and methods of use

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7816131

Cancer specific promoters

The Board of Regents of the University of Texas System · Granted Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7816097

Nucleotide and protein sequence of Mammastatin and methods of use

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7816324

Composition and method for the treatment of diseases affected by a peptide receptor

The Board of Regents of the University of Texas System · Granted Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7816529

Pyrimidines useful as modulators of voltage-gated ion channels

Vertex Pharmaceuticals Incorporated · Granted Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7816560

Long chain n-alkyl compounds and oxa-derivatives thereof

United Therapeutics Corporation · Granted Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7816352

Apoptosis inhibitors

The Regents of the University of California · Granted Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7815434

Dental coating kit

Kuraray Medical Inc. · Granted Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7820154

Use of IL-1 antagonists to treat gout

REGENERON PHARMACEUTICALS, INC. · Granted Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7820692

Tetrahydro isoquinoline derivatives, preparation methods and medicinal uses thereof

CHINA PHARMACEUTICAL UNIVERSITY · Granted Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7820685

Aminopyrimidines useful as kinase inhibitors

Vertex Pharmaceuticals Incorporated · Granted Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7820671

Peptidomimetic protease inhibitors

Vertex Pharmaceuticals Incorporated · Granted Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7820663

Substituted enaminones, their derivatives and uses thereof

The Regents of the University of California · Granted Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7820631

Anti-viral pyrimidine nucleoside analogues

University College Cardiff Consultants Limited · Granted Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7820837

Condensed ring compound

Takeda Pharmaceutical Company Limited · Granted Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7820395

Orientia tsutsugamushi truncated recombinant outer membrane protein (R47) and (R56) vaccines diagnostics and therapeutics for scrub typhus

United States of America as represented by the Secretary of the Air Force · Granted Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7820162

Methods for chemically synthesizing immunoglobulin chimeric proteins

Syntonix Pharmaceuticals, Inc. · Granted Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7820174

T cell receptors and related materials and methods of use

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7820181

Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from cDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7820182

Production of attenuated, human-bovine chimeric respiratory syncytial viruses for use in immunogenic compositions

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7820447

Compositions and methods for cancer

Sagres Discovery, Inc. · Granted Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7820398

Immunosorbent blood tests for assessing paroxysmal cerebral discharges

GRACE LABORATORIES, LLC · Granted Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7820642

Nandrolone 17β-carbonates

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7820673

Urea derivative, process for producing the same, and use

Takeda Pharmaceutical Company Limited · Granted Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7820634

Composition and method for production of transformed cells

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7820695

Selective serotonin receptor inverse agonists as therapeutics for disease

ACADIA Pharmaceuticals Inc. · Granted Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7820733

Dental polymerizable core build-up material of separately packed type

Kuraray Medical Inc. · Granted Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7820784

Orally administered peptides synergize statin activity

The Regents of the University of California · Granted Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7820817

Modulators of muscarinic receptors

Vertex Pharmaceuticals Incorporated · Granted Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7820819

2,4-pyrimidinediamine compounds and their uses

Rigel Pharmaceuticals, Inc. · Granted Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)